Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study

BACKGROUND: Vaccine effectiveness against the severe acute respiratory syndrome coronavirus 2 Omicron BA.2 sublineage in Japan is unknown. We assessed the effectiveness of a third dose of COVID-19 mRNA vaccine compared with that of 2 doses. METHODS: We performed a population-based cohort study using...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimura, Wataru, Ishiguro, Chieko, Maeda, Megumi, Murata, Fumiko, Fukuda, Haruhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792082/
https://www.ncbi.nlm.nih.gov/pubmed/36589480
http://dx.doi.org/10.1093/ofid/ofac636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792082/
https://www.ncbi.nlm.nih.gov/pubmed/36589480
http://dx.doi.org/10.1093/ofid/ofac636

Ejemplares similares